ABBOTT INDIA LIMITED
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-term to Patients With Rheumatoid Arthritis
- Conditions
- Interventions
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2011-11-22
- Lead Sponsor
- Abbott
- Target Recruit Count
- 796
- Registration Number
- NCT00233571
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2008-07-22
- Lead Sponsor
- Abbott
- Target Recruit Count
- 2000
- Registration Number
- NCT00233532
Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-08-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 400
- Registration Number
- NCT00195689
- Locations
- 🇺🇸
Global Medical Information-Abbott Laboratories, Abbott Park, Illinois, United States
A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-07-02
- Lead Sponsor
- Abbott
- Target Recruit Count
- 227
- Registration Number
- NCT00195780
- Locations
- 🇺🇸
Kolin Research Group, Winter Park, Florida, United States
🇺🇸Clinco, Terre Haute, Indiana, United States
🇺🇸Rakesh Ranjan, M.D. & Associates, Inc., Lyndhurst, Ohio, United States
Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-03-19
- Lead Sponsor
- Abbott
- Target Recruit Count
- 150
- Registration Number
- NCT00195767
- Locations
- 🇺🇸
Global Medical Information-Abbott, North Chicago, Illinois, United States
The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2007-02-08
- Lead Sponsor
- Abbott
- Target Recruit Count
- 300
- Registration Number
- NCT00195741
- Locations
- 🇺🇸
Global Medical Information - Abbott, North Chicago, Illinois, United States
Long Term Open Label Continuation Study
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2012-08-31
- Lead Sponsor
- Abbott
- Target Recruit Count
- 846
- Registration Number
- NCT00195650
- Locations
- 🇺🇸
Site Reference ID/Investigator# 541, Danbury, Connecticut, United States
🇺🇸Site Reference ID/Investigator# 574, Fort Myers, Florida, United States
🇺🇸Site Reference ID/Investigator# 646, Statesville, North Carolina, United States
Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2011-08-26
- Lead Sponsor
- Abbott
- Target Recruit Count
- 619
- Registration Number
- NCT00195702
- Locations
- 🇺🇸
Site Ref # / Investigator 358, Voorhees, New Jersey, United States
🇺🇸Site Ref # / Investigator 60736, Anaheim, California, United States
🇺🇸Site Ref # / Investigator 712, Danbury, Connecticut, United States
Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2011-07-12
- Lead Sponsor
- Abbott
- Target Recruit Count
- 777
- Registration Number
- NCT00195715
- Locations
- 🇺🇸
Site Ref # / Investigator 1881, Annapolis, Maryland, United States
🇺🇸Site Ref # / Investigator 1878, Arlington Heights, Illinois, United States
🇺🇸Site Ref # / Investigator 1827, Clearwater, Florida, United States
Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis
- Conditions
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2011-06-28
- Lead Sponsor
- Abbott
- Target Recruit Count
- 82
- Registration Number
- NCT00195819
- Locations
- 🇨🇦
Site Ref # / Investigator 64, Winnipeg, Manitoba, Canada
🇨🇦Site Ref # / Investigator 74, Calgary, Alberta, Canada
🇨🇦Site Ref # / Investigator 70, Edmonton, Alberta, Canada